Alan Fleischer, MD
Professor and Chair of Dermatology
Wake Forest University School of Medicine - CC
Wake Forest University School of Medicine - CC
Member of the Healthcare Council
Alan Fleischer, MD, is Professor and Chair of Dermatology at the Wake Forest University School of Medicine. In addition to his general and surgical dermatology practice, he has been primary investigator on dozens of Phase I through Phase IV clinical trials. Dr. Fleischer has published extensively on the delivery of dermatologic healthcare in the U.S. The primary disease states he has investigated include the inflammatory diseases, especially psoriasis, atopic dermatitis, urticaria, acne and rosacea. Dr. Fleischer consults for several pharmaceutical companies and has ongoing grant support for his research efforts. (This is me - Update Profile)
| 1991 - present | Professor and Chair of Dermatology Wake Forest University School of Medicine - CC |
|---|
GLG Study Groups with Alan Fleischer, MD(?)
| Study Group Name | Members |
|---|---|
| Dermatologists (US) | 582 |
| Physicians who Treat Rosacea (US) | 126 |
| Physicians who treat Actinic keratoses | 90 |
| Physicians who Treat Acne (US) | 278 |
GLG NewsSM Analyses by Alan Fleischer, MD(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
Alan Fleischer, MD has not published any public GLG News analyses.
View all GLG News in Healthcare
View all GLG News in Healthcare
GLG InstituteSM Seminars with Alan Fleischer, MD(?)
Alan Fleischer, MD has not participated in any GLGi Seminars.
View all GLG InstituteSM Seminars in Healthcare
View all GLG InstituteSM Seminars in Healthcare
Request a project with Alan Fleischer, MD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
40 of the leading 50
global mutual funds
global mutual funds
15 of the leading 20
global banks
global banks
8 of the leading 10
private equity firms
private equity firms
90%+ client subscription renewal rate

